Vistin Pharma ASA (OSL:VISTN)

Norway flag Norway · Delayed Price · Currency is NOK
19.80
-0.05 (-0.25%)
At close: Dec 4, 2025
-17.84%
Market Cap 917.93M
Revenue (ttm) 455.25M
Net Income (ttm) 78.06M
Shares Out 44.34M
EPS (ttm) 1.76
PE Ratio 11.76
Forward PE n/a
Dividend 1.25 (6.31%)
Ex-Dividend Date n/a
Volume 26,458
Average Volume 30,862
Open 19.60
Previous Close 19.85
Day's Range 19.60 - 20.10
52-Week Range 19.40 - 27.30
Beta 0.64
RSI 35.40
Earnings Date Apr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Sector Healthcare
Founded 1969
Employees 75
Stock Exchange Oslo Børs
Ticker Symbol VISTN
Full Company Profile

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial Statements

News

There is no news available yet.